Orion Oyj

Orion Oyj is a company in Espoo, Finland that has taken part in 26 EU-funded projects since 2008, receiving €142k in EU funding.

EU funding received€142k
EU projects26
As coordinator0
Running now7
First EU project2008
Latest project2027
CountryFinland
EU registration (PIC)999790544
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Orion Oyj's own share of each project, not the project's full budget.

  • FP7 (2007 to 2013)€93k · 12 projects
  • Horizon 2020€49k · 6 projects
  • Horizon Europe€0 · 8 projects

Projects

26 EU-funded projects, newest first. Each links to the official record.

  • RESDOCAssociated partner

    Training Doctoral Excellence for Resilient and Just Future

    Horizon Europe · 2027–2031 · Project on CORDIS ↗

  • SciLifeLab PULSEAssociated partner

    SciLifeLab Programme for fUture Leaders in life SciencE

    Horizon Europe · 2025–2030 · Project on CORDIS ↗

  • IMMUFELLOWAssociated partner

    Interdisciplinary and Intersectoral Research Fellowship Program for Future Leaders in Immunology

    Horizon Europe · 2025–2030 · Project on CORDIS ↗

  • HAIFAssociated partner

    Human-Centric Artificial Intelligence for Sustainable Future

    Horizon Europe · 2025–2029 · Project on CORDIS ↗

  • NOVELAssociated partner

    Novel brain health solutions across four focus areas: Prevention and care, Methods and data, Innovation and society, and Ethics and well-being

    Horizon Europe · 2024–2029 · Project on CORDIS ↗

  • VICT3RPartner

    Developing and implementing VIrtual Control groups To reducE animal use in toxicology Research

    Horizon Europe · 2024–2028 · Project on CORDIS ↗

  • ETERNITYAssociated partner

    FuEl ThE bRaiN In healtThY aging and agE-relateD diseases

    Horizon Europe · 2023–2027 · Project on CORDIS ↗

  • TransPharmPartner

    Transforming into a sustainable European pharmaceutical sector

    Horizon Europe · 2022–2026 · Project on CORDIS ↗

  • IDEA-FASTPartner

    Identifying Digital Endpoints to Assess FAtigue, Sleep and acTivities in daily living in Neurodegenerative disorders and Immune-mediated inflammatory diseases

    Horizon 2020 · 2019–2026 · Project on CORDIS ↗

  • PIONEERPartner

    Prostate Cancer DIagnOsis and TreatmeNt Enhancement through the Power of Big Data in EuRope

    Horizon 2020 · 2018–2023 · Project on CORDIS ↗

  • EQIPDPartner

    European Quality In Preclinical Data

    Horizon 2020 · 2017–2021 · Project on CORDIS ↗

  • TransQSTPartner

    Translational quantitative systems toxicology to improve the understanding of the safety of medicines - Sofia: 116030

    Horizon 2020 · 2017–2022 · Project on CORDIS ↗

  • TreatERPartner

    Clinical study in Parkinson's disease with two unique goals: 1) Proof-of-concept of CDNF protein for disease modification; 2) Validation of clinically tested device for intracerebral drug delivery

    Horizon 2020 · 2017–2020 · Project on CORDIS ↗

    €49ktheir share
  • PHAGOPartner

    Inflammation and AD: modulating microglia function focussing on TREM2 and CD33 - Sofia ref.: 115976

    Horizon 2020 · 2016–2022 · Project on CORDIS ↗

  • CANCER-IDPartner

    Cancer treatment and monitoring through identification of circulating tumour cells and tumour related nucleic acids in blood

    FP7 (2007 to 2013) · 2015–2019 · Project on CORDIS ↗

  • CHEM21Partner

    Chemical Manufacturing Methods for the 21st Century Pharmaceutical Industries

    FP7 (2007 to 2013) · 2012–2017 · Project on CORDIS ↗

  • ORBITOPartner

    Oral biopharmaceutics tools

    FP7 (2007 to 2013) · 2012–2018 · Project on CORDIS ↗

  • STEMBANCCPartner

    Stem cells for Biological Assays of Novel drugs and prediCtive toxiCology (StemBANCC)

    FP7 (2007 to 2013) · 2012–2018 · Project on CORDIS ↗

  • MIP-DILIPartner

    Mechanism-Based Integrated Systems for the Prediction of Drug-Induced Liver Injury

    FP7 (2007 to 2013) · 2012–2017 · Project on CORDIS ↗

  • PREDECTPartner

    New Models for Preclinical Evaluation of Drug Efficacy in Common Solid Tumours

    FP7 (2007 to 2013) · 2011–2016 · Project on CORDIS ↗

  • SAFESCIMETPartner

    European Modular Education and Training Programme in Safety Sciences for Medicines

    FP7 (2007 to 2013) · 2010–2016 · Project on CORDIS ↗

  • EMTRAINPartner

    European Medicines Research Training Network

    FP7 (2007 to 2013) · 2009–2016 · Project on CORDIS ↗

  • NEWMEDSPartner

    Novel Methods leading to New Medications in Depression and Schizophrenia

    FP7 (2007 to 2013) · 2009–2015 · Project on CORDIS ↗

  • EU2PPartner

    European programme in Pharmacovigilance and Pharmacoepidemiology

    FP7 (2007 to 2013) · 2009–2016 · Project on CORDIS ↗

  • PHARMATRAINPartner

    Pharmaceutical Medicine Training Programme

    FP7 (2007 to 2013) · 2009–2014 · Project on CORDIS ↗

  • PROSPERPartner

    Prostate cancer: profiling and evaluation of ncRNA

    FP7 (2007 to 2013) · 2008–2012 · Project on CORDIS ↗

    €93ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • RNA
  • adverse drug reactions
  • alzheimer
  • artificial intelligence
  • biocatalysis
  • bioreactors
  • breast cancer
  • business models
  • cardiac arrhythmia
  • cell biology
  • cognitive neuroscience
  • crystals
  • data science
  • databases

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime